CSW Industrials CEO sells 1,500 shares avg $289.58
CSW Industrials’ CEO executed a 1,500-share sale under a Rule 10b5-1 plan while retaining significant direct, indirect, and equity-award-based exposure to CSW common stock.
Rhea-AI Filing Summary
CSW INDUSTRIALS, INC. (CSW) reported that Chairman, President & CEO Joseph B. Armes sold 1,500 shares of common stock on September 15, 2026 in a sale reported as occurring in the open market or a private transaction at a weighted average price of $289.584 per share, with individual trades ranging from $288.145 to $290.35, pursuant to a Rule 10b5-1 trading plan established on August 12, 2025. Following this sale, he held 62,736 shares of common stock directly and 3,219 shares indirectly through an ESOP, plus multiple outstanding equity awards, including performance rights over 9,836, 8,004, 8,236 and 9,186 underlying shares and 19,685 restricted stock units that may settle in cash or common stock based on future vesting conditions linked to relative total shareholder return and the recruitment and tenure of a successor Chief Executive Officer.
Positive
- None.
Negative
- None.
Insights
Analyzing...
Insider Trade Summary 10b5-1
Net Seller: 1,500 shares
Net Sell
7 txns
Insider
Armes Joseph B
Role
Chairman, President & CEO
Sold
1,500 shs ($434K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock F1, F2 | 1,500 | $289.584 | $434K |
| holding | Performance Rights F3 | -- | -- | -- |
| holding | Performance Rights F4 | -- | -- | -- |
| holding | Performance Rights F5 | -- | -- | -- |
| holding | Performance Rights F6 | -- | -- | -- |
| holding | Restricted Stock Units F7 | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Common Stock — 62,736 shares (Direct);
Performance Rights — 35,262 contracts (Direct);
Restricted Stock Units — 19,685 contracts (Direct);
Common Stock — 3,219 shares (Indirect, by ESOP)
Footnotes (7)
- F1. The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on August 12, 2025.
- F2. The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $288.145 to $290.35, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- F3. Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 250% during a three-year performance cycle beginning on April 1, 2026 and ending on March 31, 2029 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.
- F4. Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2025, and ending on March 31, 2028, based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.
- F5. Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2024, and ending on March 31, 2027, based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.
- F6. Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200%, during a performance cycle beginning April 1, 2021 and ending on March 31, 2027 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.
- F7. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock at vesting. 40% of the restricted stock units vest no earlier than April 26, 2025 upon the successful recruitment and hiring of a successor Chief Executive Officer; the remaining 60% vest upon the successful first employment anniversary of a successor Chief Executive Officer.
Key Figures
Shares sold: 1,500 shares
Weighted average sale price: $289.584 per share
Sale price range: $288.145–$290.35 per share
+5 more
8 metrics
Shares sold
1,500 shares
Sale of CSW common stock on September 15, 2026
Weighted average sale price
$289.584 per share
Common stock sale on September 15, 2026
Sale price range
$288.145–$290.35 per share
Range of prices for the 1,500 shares sold
Direct common stock holdings after sale
62,736 shares
Direct CSW holdings reported following the transaction
Indirect ESOP holdings
3,219 shares
Common stock held indirectly by ESOP
Performance rights underlying shares (grant 1)
9,836 shares
Performance rights beginning April 1, 2026
Performance rights underlying shares (grant 2–4)
8,004; 8,236; 9,186 shares
Additional performance rights grants with earlier cycles
Restricted stock units underlying shares
19,685 shares
RSUs linked to successor CEO recruitment and first anniversary
Key Terms
Rule 10b5-1 trading plan, performance rights, restricted stock unit, relative total shareholder return, +2 more
6 terms
Rule 10b5-1 trading plan regulatory
"The transaction reported was effected pursuant to a 10b5-1 trading plan"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
performance rights financial
"Each performance right represents a contingent right to receive one share"
Performance rights are conditional awards that give employees or executives the promise of receiving company shares or cash only if the business meets specific targets or survives for a set period. They work like a bonus you only get when certain goals are hit, so they matter to investors because they can increase the number of shares outstanding (dilution), signal management’s incentives and confidence in future results, and affect per-share earnings and valuation.
restricted stock unit financial
"Each restricted stock unit represents a contingent right to receive one share"
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
Russell 2000 Index market
"comparison to the total shareholder return performance among the Russell 2000 Index"
A stock-market benchmark that tracks about 2,000 small-cap U.S. companies, the Russell 2000 gives a snapshot of how smaller publicly traded firms are performing. Investors use it like a thermometer or yardstick for the small-company segment of the market—funds and portfolio managers compare returns to it, and its movements can signal changes in economic risk appetite or growth expectations; it is weighted so larger small companies have a bigger influence on the index.
ESOP financial
"Common Stock held indirectly by ESOP"
An Employee Stock Ownership Plan (ESOP) is a program that gives employees ownership shares in their company, often as part of their benefits package. It acts like a company-sponsored savings plan, allowing workers to have a stake in the company's success, which can boost motivation and loyalty. For investors, ESOPs can influence company decisions and stock value, making them an important aspect of corporate ownership and governance.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did CSW’s CEO Joseph B. Armes report on this Form 4 for CSW?
He reported a sale of 1,500 shares of CSW common stock on September 15, 2026, executed as a sale in the open market or a private transaction under a Rule 10b5-1 trading plan adopted on August 12, 2025.
What equity awards linked to CSW common stock does the CEO still hold?
He holds performance rights over 9,836, 8,004, 8,236, and 9,186 underlying CSW shares, plus 19,685 restricted stock units, each representing a contingent right to receive one share of CSW common stock at vesting.
How do the CSW performance rights for the CEO vest?
Each performance right represents a contingent right to receive one CSW share. They vest between 0% and 200–250% over three-year performance cycles beginning April 1 of 2021, 2024, 2025, or 2026, based on relative total shareholder return versus the Russell 2000 Index.
What are the vesting conditions for the CEO’s restricted stock units in CSW?
Each restricted stock unit represents a contingent right to receive one CSW share. 40% vest no earlier than April 26, 2025 upon successful recruitment and hiring of a successor CEO, and the remaining 60% vest upon that successor CEO’s successful first employment anniversary.
AI-generated analysis. How Rhea-AI works. Not financial advice.
